T-cell response
The cellular arm of adaptive immunity. CD8 "killer" T-cells eliminate infected cells outright; CD4 "helper" T-cells coordinate the broader response and license antibody production. Both arms generate long-lived memory.
How researchers study it
T-cell responses are typically measured by stimulating blood samples with viral peptide pools (such as overlapping fragments of the spike protein) and measuring activation markers, cytokine release, or proliferation. Methods include ELISPOT, intracellular cytokine staining, and activation-induced marker assays. For SARS-CoV-2, T-cell responses targeting spike and other viral proteins have been detected in nearly all infected and vaccinated individuals studied (Grifoni et al., Cell, 2020, PubMed 32668444).
Importantly, T-cell responses appear to be more durable and more variant-cross-reactive than antibody responses against SARS-CoV-2. A 2022 paper showed that T-cell recognition of spike epitopes is largely preserved across variants including Omicron, even when neutralizing antibody titers drop substantially (Tarke et al., Cell, 2022, PubMed 35114686). This is one reason vaccination continues to reduce severe disease even against variants that partially escape antibody recognition.
Long-term studies of memory T-cells from the original SARS outbreak (2003) have detected SARS-specific T-cell responses 17+ years later, suggesting durable cellular memory for coronaviruses is the norm rather than the exception. The NIAID maintains an overview of immune-system research priorities.
Common misconceptions
- Grifoni A et al. "Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals." Cell, 2020. PubMed: 32668444
- Tarke A et al. "SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to Omicron." Cell, 2022. PubMed: 35114686
- NIH NIAID. "Immune System Research." niaid.nih.gov